Funding and costs of ChAdOx1 n-CoV-19 vaccine trial - NCT04400838 (COV002)

The request was successful.

Florence Rodgers

Dear University Hospitals Birmingham NHS Foundation Trust,

The following questions relate to the ChAdOx1 n-CoV-19 vaccine trial conducted at your institution (NCT04400838 (COV002)). The vaccine referred to is also known as the Oxford-AstraZeneca vaccine or Vaxzevira.

Under the Freedom of Information Act 2000, please provide me with all of the following:

1) Details of all parties that have contributed funding to the trust in relation to the ChAdOx1 nCoV-19 vaccine trial being conducted at your site/s.
2) A list of all sites within your trust that ChAdOx1 n-CoV-19 vaccine trials have been conducted at.
3) Numbers of ChAdOx1 n-CoV-19 vaccine trial participants at each trial location.
4) Number of staff involved in conducting the trial at each trial location, listing their roles.
5) What costs were incurred by the trust in order to conduct the vaccine trial?
6) A breakdown of any funding received from internal and external sources in order to conduct the vaccine trial. Please break funding down into 1) funding from public (governmental) bodies, 2) private entities, and 3) philanthropies/charitable bodies. Please include the full name of the funding body. Please specify amounts in GBP. (Please provide this as an excel spreadsheet)
7) A record of all expenses incurred in conducting the ChAdOx1 n-CoV-19 vaccine trial.
This may include: unit costs of test, fees to central laboratories, investigator fees, data management costs.

Format: please provide the reply to our request in the form of an Excel sheet where possible.
END OF FOI

Yours faithfully,
Florence Rodgers

FOI, University Hospitals Birmingham NHS Foundation Trust

1 Attachment

Our reference: FOI 1486 2021/22

Dear Florence Rogers,

Thank you for your request for information. The Trust's response is provided in the attached document. Please accept our apologies for the delay in providing our response, this has likely been due to urgent responses in relation to public health priorities.

University Hospitals Birmingham NHS Foundation Trust (UHB) completed a merger by acquisition of Heart of England NHS Foundation Trust (HEFT) on 1st April 2018.

UHB is one of the largest teaching hospital trusts in England, serving a regional, national and international population. It includes Birmingham Heartlands Hospital, the Queen Elizabeth Hospital Birmingham, Solihull Hospital and Community Services, Good Hope Hospital in Sutton Coldfield and Birmingham Chest Clinic. We also run a number of smaller satellite units, allowing people to be treated as close to home as possible. We see and treat more than 2.2 million people every year across our sites and our hospitals deliver more babies than anywhere else in Europe. We employ 20,000 staff and have an annual turnover of nearly £1.5 billion.

If you are unhappy with the service you have received in relation to your request and wish to request a review of our decision, you should email [email address] or write to the Information Governance Lead, Corporate Affairs, 3rd Floor, Nuffield House, Queen Elizabeth Hospital, Birmingham, B15 2GW

If you are not content with the outcome of your review, you may apply directly to the Information Commissioner for a decision. Generally, the ICO cannot make a decision unless you have exhausted the complaints procedure provided by our Trust. The Information Commissioner can be contacted at:

Information Commissioner's Office Wycliffe House Water Lane, Wilmslow, Cheshire SK9 5AF Telephone: 08456 30 60 60 or 01625 54 57 45 or www.ico.org.uk

Kind regards,

FOI Officer

Information Governance Team
University Hospitals Birmingham
Email: [email address]

show quoted sections